TRICORTIN
Field of Activity:
Application:
Release form:
Composition:
Indications for use – polymyalgic neurosis syndrome Directions for use and doses 2 ml is administered intramuscularly once a day as prescribed by the doctor. Side effects There have been no reported side effects that could be attributed to this drug. Overdose No overdose symptoms were reported. Contraindications – hypersensitivity to the components of the drug or other substances, similar in chemical structure – children and adolescents up to 18 years of age Drug interactions There have been no reports of interactions with other drugs. There are no known cases of incompatibility of TRICORTIN® with other drugs. Special instructions Pregnancy and lactation The drug can be administered during pregnancy and lactation under the direct supervision of a physician. Features of the drug’s influence on the ability to drive a vehicle or potentially dangerous machinery The drug does not affect the ability to drive a car or operate machinery. Release form and packaging 2 ml in orange glass ampoules type I, with a breaking point. 5 ampoules per blister pack made of polyvinyl chloride film. 1 blister pack together with instructions for medical use in the state and Russian languages are placed in a cardboard box. Storage conditions Store at a temperature not exceeding 25°C Keep out of the reach of children! Shelf life 2 years Do not use after the expiration date! Conditions for dispensing from pharmacies On prescription Manufacturer/Packager Fidia Pharmaceutisi S.P.A., 35031, Abano Terme, Via Ponte della Fabbrica, 3/A, Italy Registration Certificate Holder Fidia Pharmaceutisi S.P.A., 35031, Abano Terme, Via Ponte della Fabbrica, 3/A, Italy
Indications for use
- polymyalgic neurosis syndrome
Directions for use and doses
2 ml is administered intramuscularly once a day as prescribed by the doctor.
Side effects
There have been no reported side effects that could be attributed to this drug.
Overdose
No overdose symptoms were reported.
Contraindications
- hypersensitivity to the components of the drug or other substances,
similar in chemical structure
- children and adolescents up to 18 years of age
Drug interactions
There have been no reports of interactions with other drugs.
There are no known cases of incompatibility of TRICORTIN® with other drugs.
Special instructions
Pregnancy and lactation
The drug can be administered during pregnancy and lactation under the direct supervision of a physician.
Features of the drug's influence on the ability to drive a vehicle or potentially dangerous machinery
The drug does not affect the ability to drive a car or operate machinery.
Release form and packaging
2 ml in orange glass ampoules type I, with a breaking point.
5 ampoules per blister pack made of polyvinyl chloride film.
1 blister pack together with instructions for medical use in the state and Russian languages are placed in a cardboard box.
Storage conditions
Store at a temperature not exceeding 25°C
Keep out of the reach of children!
Shelf life
2 years
Do not use after the expiration date!
Conditions for dispensing from pharmacies
On prescription
Manufacturer/Packager
Fidia Pharmaceutisi S.P.A.,
35031, Abano Terme, Via Ponte della Fabbrica, 3/A, Italy
Registration Certificate Holder
Fidia Pharmaceutisi S.P.A.,
35031, Abano Terme, Via Ponte della Fabbrica, 3/A, Italy